- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Apollo Hospitals reported robust financial results for the quarter and nine-month period ended December 31, 2025.
**Financial Performance:**
For Q3 FY26, consolidated revenue grew 17% YoY to **₹6,477.4 Cr**, with EBITDA up 27% YoY to **₹965.3 Cr**, and PAT jumping 35% YoY to **₹502.3 Cr**. For YTD Dec 25, consolidated revenue rose 15% to **₹18,623 Cr**, EBITDA 22% to **₹2,758.4 Cr**, and PAT 34% to **₹1,412.3 Cr**.
**Segment Highlights:**
Healthcare Services saw revenue increase 14% and EBITDA 18% with a 24.8% margin, driven by 11% growth in average revenue per inpatient. Apollo Health & Lifestyle (AHLL) revenue grew 20%, and EBITDA 39%. Apollo HealthCo's revenue climbed 20%, with a significant 126% rise in EBITDA and 170% increase in PAT. Its platform GMV hit **₹525 Cr** (up 28% YoY), achieving its lowest digital cash loss of **₹29.2 Cr**.
**Operational & Strategic Updates:**
The company is expanding its Healthcare Services, planning to add **~3,600 census beds** over five years with a total project cost of **~₹8,200 Cr**. Two new facilities, Pune (75 beds) and Defence Colony (30 beds), became operational this quarter. Apollo HealthCo's composite scheme for direct listing as an Indian-owned and controlled company is progressing, aiming for an estimated Q4 FY27 listing. The company anticipates achieving **₹25,000 Cr** in annualized run-rate revenue by Q4 FY27 with a 7% EBITDA.
**Investor Angle:**
The company demonstrates strong growth across all segments, particularly digital health, and is aggressively expanding its hospital network. Management’s outlook appears positive, underscoring confidence in future operational performance and strategic initiatives.